How much did Beigene achieve in EBIT for the current year?
In the current year, Beigene has achieved an EBIT of -4.92 B USD.
Beigene EBIT 2024
Beigene EBIT
-4.92 B USD
Ticker
6160.HK
ISIN
KYG1146Y1017
WKN
A144EN
In 2024, Beigene's EBIT was -4.92 B USD, a -43.74% increase from the -8.75 B USD EBIT recorded in the previous year.
The Beigene EBIT history
| YEAR | EBIT (undefined USD) |
|---|---|
| 2029e | - |
| 2028e | 13.86 |
| 2027e | 8.58 |
| 2026e | 1.6 |
| 2025e | -2.57 |
| 2024e | -4.92 |
| 2023 | -8.75 |
| 2022 | -12.03 |
| 2021 | -9.47 |
| 2020 | -11.36 |
| 2019 | -6.8 |
| 2018 | -4.83 |
Beigene Revenue, EBIT, Net Income KYG1146Y1017 · A144EN
3 years
5 years
10 years
25 Years
Max
Revenue
EBIT
Net Income
Details
Revenue, EBIT and Profit
ⓘUnderstanding Revenue, EBIT, and Income
Gain insights into Beigene, a comprehensive overview of its financial performance can be obtained by analyzing the Revenue, EBIT, and Income chart. Revenue represents the total income generated by Beigene from its primary operations, showcasing the company’s ability to attract and retain clients. EBIT, or Earnings Before Interest and Taxes, indicates the company’s operational profitability, free from the influence of tax and interest expenses. The Income section reflects Beigene’s net earnings, an ultimate measure of its financial health and profitability.
Yearly Analysis and Comparisons
Observe the yearly bars to understand the annual performance and growth of Beigene. Compare the Revenue, EBIT, and Income to evaluate the company’s efficiency and profitability. A higher EBIT compared to the previous year suggests an improvement in operational efficiency. Likewise, an increase in Income indicates enhanced overall profitability. Analyzing the year-to-year comparison assists investors in understanding the company’s growth trajectory and operational efficiency.
Utilizing Expectations for Investment
The expected values for the forthcoming years offer investors a glimpse into Beigene’s anticipated financial performance. Analyzing these projections alongside historical data aids in making informed investment decisions. Investors can gauge the potential risks and returns, aligning their investment strategies accordingly to optimize profitability and mitigate risks.
Investment Insights
Leveraging the comparison between Revenue and EBIT helps in assessing Beigene’s operational efficiency, while the Revenue and Income comparison reveals the net profitability after accounting for all expenses. Investors can derive valuable insights by meticulously analyzing these financial parameters, laying the foundation for strategic investment decisions aimed at capitalizing on Beigene’s growth potential.
Beigene Revenue, EBIT and net profit per share
| Date | Beigene Revenue | Beigene EBIT | Beigene Net Income |
|---|---|---|---|
| 2029e | 54.91 B undefined | 0 undefined | 276.85 B undefined |
| 2028e | 51.92 B undefined | 13.86 B undefined | 292.76 B undefined |
| 2027e | 45.79 B undefined | 8.58 B undefined | 152.08 B undefined |
| 2026e | 38.65 B undefined | 1.6 B undefined | 5.45 B undefined |
| 2025e | 32.81 B undefined | -2.57 B undefined | -1.8 B undefined |
| 2024e | 26.29 B undefined | -4.92 B undefined | -7.97 B undefined |
| 2023 | 17.42 B undefined | -8.75 B undefined | -6.72 B undefined |
| 2022 | 9.57 B undefined | -12.03 B undefined | -13.64 B undefined |
| 2021 | 7.59 B undefined | -9.47 B undefined | -9.75 B undefined |
| 2020 | 2.12 B undefined | -11.36 B undefined | -11.38 B undefined |
| 2019 | 2.95 B undefined | -6.8 B undefined | -6.91 B undefined |
| 2018 | 1.31 B undefined | -4.83 B undefined | -4.75 B undefined |
| Revenue | EBIT | Net Income | |
|---|---|---|---|
| 2018 | 1.31 B USD | -4.83 B USD | -4.75 B USD |
| 2019 | 2.95 B USD | -6.8 B USD | -6.91 B USD |
| 2020 | 2.12 B USD | -11.36 B USD | -11.38 B USD |
| 2021 | 7.59 B USD | -9.47 B USD | -9.75 B USD |
| 2022 | 9.57 B USD | -12.03 B USD | -13.64 B USD |
| 2023 | 17.42 B USD | -8.75 B USD | -6.72 B USD |
| 2024e | 26.29 B USD | -4.92 B USD | -7.97 B USD |
| 2025e | 32.81 B USD | -2.57 B USD | -1.8 B USD |
| 2026e | 38.65 B USD | 1.6 B USD | 5.45 B USD |
| 2027e | 45.79 B USD | 8.58 B USD | 152.08 B USD |
| 2028e | 51.92 B USD | 13.86 B USD | 292.76 B USD |
| 2029e | 54.91 B USD | 0 USD | 276.85 B USD |
Beigene stock margins KYG1146Y1017 · A144EN
The Beigene margin analysis displays the gross margin, EBIT margin, as well as the profit margin of Beigene. The EBIT margin (EBIT/sales) indicates the percentage of sales that remains as operating profit. The profit margin shows the percentage of sales that remains for Beigene.
3 years
5 years
10 years
25 Years
Max
Gross margin
EBIT margin
Profit margin
Details
Margin
ⓘUnderstanding Gross Margin
The gross margin, expressed as a percentage, delineates the gross profit made from the Beigene's sales revenue. A higher gross margin percentage indicates that the Beigene retains more revenue after accounting for the costs of goods sold. Investors use this metric to gauge financial health and operational efficiency, as well as to compare it with competitors and industry averages.
EBIT Margin Analysis
EBIT margin represents the Beigene's earnings before interest and taxes. Analyzing the EBIT margin over different years provides insights into the operational profitability and efficiency, excluding the effects of financial leverage and tax structure. A growing EBIT margin over the years signifies improving operational performance.
Revenue Margin Insights
The revenue margin demonstrates the Beigene's total revenue generated. When comparing the revenue margin year over year, investors can gauge the Beigene's growth and market expansion. It is essential to compare the revenue margin with the gross and EBIT margins to understand the cost and profit structures better.
Interpreting Expectations
The expected values for gross, EBIT, and revenue margins provide future financial outlook of the Beigene. Investors should compare these expectations with historical data to understand potential growth and risk factors. It is crucial to consider the underlying assumptions and methodologies used in projecting these expected values to make informed investment decisions.
Comparative Analysis
Comparing the gross, EBIT, and revenue margins, both yearly and over multiple years, enables investors to perform a comprehensive analysis of the Beigene's financial health and growth prospects. Evaluating the trends and patterns in these margins helps in identifying strengths, weaknesses, and potential investment opportunities.
Beigene Margin History
| Beigene Gross margin | Beigene Profit margin | Beigene EBIT margin | Beigene Profit margin |
|---|---|---|---|
| 2029e | 84.45 % | 0 % | 504.22 % |
| 2028e | 84.45 % | 26.7 % | 563.83 % |
| 2027e | 84.45 % | 18.73 % | 332.11 % |
| 2026e | 84.45 % | 4.14 % | 14.09 % |
| 2025e | 84.45 % | -7.83 % | -5.49 % |
| 2024e | 84.45 % | -18.72 % | -30.31 % |
| 2023 | 84.45 % | -50.22 % | -38.55 % |
| 2022 | 80.1 % | -125.71 % | -142.6 % |
| 2021 | 86.02 % | -124.77 % | -128.45 % |
| 2020 | 77.09 % | -535.92 % | -536.92 % |
| 2019 | 83.38 % | -230.07 % | -234.08 % |
| 2018 | 85.52 % | -368.81 % | -362.35 % |
| Gross margin | EBIT margin | Profit margin | |
|---|---|---|---|
| 2018 | 85.52 % | -368.81 % | -362.35 % |
| 2019 | 83.38 % | -230.07 % | -234.08 % |
| 2020 | 77.09 % | -535.92 % | -536.92 % |
| 2021 | 86.02 % | -124.77 % | -128.45 % |
| 2022 | 80.1 % | -125.71 % | -142.6 % |
| 2023 | 84.45 % | -50.22 % | -38.55 % |
| 2024e | 84.45 % | -18.72 % | -30.31 % |
| 2025e | 84.45 % | -7.83 % | -5.49 % |
| 2026e | 84.45 % | 4.14 % | 14.09 % |
| 2027e | 84.45 % | 18.73 % | 332.11 % |
| 2028e | 84.45 % | 26.7 % | 563.83 % |
| 2029e | 84.45 % | 0 % | 504.22 % |
Beigene Aktienanalyse
What does Beigene do?
Beigene Ltd is a Chinese biotech company that is active in cancer research. It was founded in 2010 by experienced biotech manager John Oyler. The company is now listed on NASDAQ and also has a presence in the United States. Beigene's business model is to develop and distribute innovative cancer treatments. The company utilizes its extensive expertise in molecular and cellular biology as well as clinical development. The goal is to develop therapies that specifically target tumor cells while sparing healthy tissue. This is intended to improve patient survival rates and quality of life. Beigene specializes in the development of cancer treatments, particularly immunotherapies and precision medicine. The latter utilizes targeted attacks against tumor cells at the molecular level to achieve the most focused and effective treatment possible. The company focuses primarily on rare tumor types for which there are currently few or no effective therapies. Beigene is divided into several divisions that focus on different treatment approaches. One important division is immunotherapies, which activate the patient's own immune system against the tumor. Beigene develops antibodies, for example, that recognize and attack specific tumor cells. CAR-T cell therapy is also part of the company's portfolio. In this approach, the patient's T cells are harvested, genetically modified, and multiplied in the laboratory. These T cells are then reintroduced into the patient's body, where they target the tumor specifically. Another division of Beigene is the so-called small molecule drugs. These are chemical compounds that are introduced into the body and specifically attack tumor cells. Beigene develops inhibitors, for example, that inhibit specific enzymes and thus suppress the growth of cancer cells. Beigene has been particularly successful with its drug Zanubrutinib, which is used to treat lymphomas. The drug has achieved excellent results in clinical trials and has already been approved in several countries. Overall, Beigene is an innovative and promising biotech company that specializes in the development of new cancer treatments. The company has a strong expertise in molecular biology and has already achieved promising successes. With its various divisions and products, Beigene covers a wide range of treatment approaches and is likely to play an important role in the fight against cancer in the future. Beigene ist eines der beliebtesten Unternehmen auf Eulerpool.com.EBIT Details
Analyzing Beigene's EBIT
Beigene's Earnings Before Interest and Taxes (EBIT) represents the company's operating profit. It is calculated by deducting all operating expenses, including the cost of goods sold (COGS) and operating expenses, from the total revenue, but before accounting for interest and taxes. It provides insights into the company’s operational profitability, excluding the impacts of financing and tax structures.
Year-to-Year Comparison
A yearly comparison of Beigene's EBIT can reveal trends in the company’s operational efficiency and profitability. An increase in EBIT over the years can indicate enhanced operational efficiency or growth in revenue, while a decrease might raise concerns about increased operating costs or declining sales.
Impact on Investments
Beigene's EBIT is a significant metric for investors. A positive EBIT suggests that the company is generating enough revenue to cover its operating expenses, an essential aspect for assessing the company’s financial health and stability. Investors closely monitor EBIT to gauge the company’s profitability and potential for future growth.
Interpreting EBIT Fluctuations
Fluctuations in Beigene’s EBIT can be due to variations in revenue, operating expenses, or both. An increasing EBIT indicates improved operational performance or increased sales, while a declining EBIT can signal rising operational costs or reduced revenue, prompting a need for strategic adjustments.
Frequently Asked Questions about Beigene stock
What is EBIT?
EBIT stands for Earnings Before Interest and Taxes and refers to the profit before interest and taxes of a company Beigene.
How has the EBIT of Beigene developed in recent years?
The EBIT of Beigene has increased by -43.736% decreased compared to the previous year.
What does EBIT mean for investors?
EBIT provides investors with insights into a company's profitability as it reflects the profit before interest expenses and taxes.
Why is EBIT an important indicator for investors?
Since EBIT provides a more direct insight into a company's profit than net income, it is an important indicator for investors to assess the profitability of a company.
Why do EBIT values fluctuate?
EBIT values can fluctuate as they are influenced by various factors, such as revenue, costs, and tax effects.
What role does tax burden play in EBIT?
Tax burdens have a direct impact on a company's EBIT, as they are deducted from the profit.
How is EBIT presented in the balance sheet of the company Beigene?
The EBIT of Beigene is listed in the income statement.
Can EBIT be used as a single indicator for evaluating a company?
EBIT is an important indicator for evaluating a company, but additional financial ratios should also be considered to get a comprehensive picture.
Why is EBIT not equal to net profit?
The net profit of a company includes taxes and interest, while EBIT represents the profit before interest and taxes.
How much dividend does Beigene pay?
Over the past 12 months, Beigene paid a dividend of . This corresponds to a dividend yield of about . For the coming 12 months, Beigene is expected to pay a dividend of 0 USD.
What is the dividend yield of Beigene?
The current dividend yield of Beigene is .
When does Beigene pay dividends?
Beigene pays a quarterly dividend. This is distributed in the months of .
How secure is the dividend of Beigene?
Beigene paid dividends every year for the past 0 years.
What is the dividend of Beigene?
For the upcoming 12 months, dividends amounting to 0 USD are expected. This corresponds to a dividend yield of 0 %.
In which sector is Beigene located?
Beigene is assigned to the 'Health' sector.
Wann musste ich die Aktien von Beigene kaufen, um die vorherige Dividende zu erhalten?
To receive the latest dividend of Beigene from 11/9/2024 amounting to 0 USD, you needed to have the stock in your portfolio before the ex-date on 11/9/2024.
When did Beigene pay the last dividend?
The last dividend was paid out on 11/9/2024.
What was the dividend of Beigene in the year 2023?
In the year 2023, Beigene distributed 0 USD as dividends.
In which currency does Beigene pay out the dividend?
The dividends of Beigene are distributed in USD.
Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.
Andere Kennzahlen von Beigene
Our stock analysis for Beigene Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Beigene Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.
